Do Nicotine Pouches Affect Blood Sugar?

By PouchGuide Editorial Team · Published September 14, 2026

Yes — and this is one of the clearer cases where the research specifically implicates nicotine itself, not just smoke or combustion byproducts. That distinction matters directly for nicotine pouches, since they deliver nicotine without either of those.

What the research shows

According to research summarized by the American Diabetes Association, nicotine use leads the pancreas to release less insulin, which raises blood sugar levels — and higher blood sugar is associated with higher diabetes risk. This isn’t a smoke-specific mechanism; it’s tied to nicotine’s own action on insulin release and sensitivity.

A 2019 study from Mount Sinai identified a specific biological pathway behind this: a protein encoded by a diabetes-related gene (Tcf7l2) mediates a signaling circuit connecting nicotine-activated neurons in the brain to blood-glucose regulation by the pancreas — a mechanistic explanation for why nicotine, specifically, disrupts glucose control rather than it being a side effect of smoking generally.

Is this nicotine, or is it smoking?

This is the key question for anyone using a smoke-free product, and the research here is more direct than in some other health areas: studies distinguishing nicotine from smoke exposure have found that nicotine-free cigarettes do not produce the same elevated blood glucose effect that nicotine-containing ones do — pointing at nicotine as the active factor, not the combustion. That’s a meaningful distinction for nicotine pouches, which deliver nicotine without smoke or tar, but it also means switching to a smoke-free nicotine product doesn’t remove this particular mechanism, because it’s the nicotine itself doing this, not the smoke.

What this means for insulin resistance specifically

Elevated cortisol is part of the proposed mechanism: nicotine use is associated with cortisol release, and sustained elevated cortisol can reduce insulin sensitivity over time — meaning the body responds less effectively to the insulin it does produce. Combined with reduced insulin output, this is a plausible two-part pathway toward the insulin resistance research has associated with nicotine use.

Who should pay particular attention

If you already have diabetes, prediabetes, or a family history of type 2 diabetes, this research is directly relevant to you in a way it might not be for someone with no metabolic risk factors — nicotine’s effect on insulin and blood glucose is a real, mechanistically-explained factor, not a vague association. This is general information, not medical advice, and if blood sugar management is already something you’re working on with a doctor, nicotine use (in any form, including pouches) is worth raising specifically in that conversation.

Bottom line

The research here points at nicotine itself, not smoke, as the driver of impaired insulin release and reduced insulin sensitivity — which means switching from smoking to a smoke-free nicotine pouch doesn’t eliminate this particular metabolic effect. See our general safety overview for the wider picture on what is and isn’t known about nicotine pouches specifically.